Part of the panel was meant to deal with the HPV vaccine, namely is there any objective to show that the current HPV vaccine program is not justified and what is the evidence, if any, that the HPV vaccine prevents cervical cancer and, therefore, can offer long-term benefits, because that’s the basis that they’re being promoted as a cervical cancer vaccine. And also briefly to touch on the nature and incidence of adverse events. What the clinical trials for HPV have shown is that they can prevent some portion of lesions caused by HPV-16 and -18 viruses. And so, obviously, it was deduced from that that it’s likely that they would prevent cervical cancer. The issue is can someone make such a leap making such a conclusion.